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Abstract. Separate groups of  pigeons were trained to discrim- 
inate the IM injection of ketamine, cyclazocine, or dex- 
t rorphan from saline. Each of  the training drugs and phency- 
clidine produced dose-related, drug-appropriate  responding 
in each group of birds. In contrast, ethylketazocine and 
nalorphine generally produced responding appropria te  for 
saline. These results indicate that common elements of  
discriminable effects exist among ketamine, cyclazocine, and 
dextrorphan, structurally dissimilar compounds that  are 
generally considered to belong to distinct pharmacological  
classes. 
Key words: Phencyclidine - Drug discrimination - 
Ketamine - Pigeons - Dextrorphan - Ethylketazocine - 
Cyclazocine - Nalorphine 
The discriminative stimulus effect of  a drug is often shared 
only by compounds that share the drug's  other pharmacologi-  
cal actions (Barry 1974; Weissman 1978). For  example, when 
morphine is established as a discriminative stimulus, a variety 
of narcotic analgesics (e. g., methadone, levorphanol) pro-  
duce responding appropria te  for morphine, while dextror- 
phan and thebaine, compounds that  are structurally related 
to narcotics but  lack many narcotic actions, are without 
morphine-like discriminative effects (Shannon and Hol tzman 
1976). Similarly, drugs from several other pharmacological  
classes - e. g., cannabinoids (Weissman 1978), barbiturates 
(Colpaert  et al. 1976) - appear  to produce discriminative 
stimulus effects that are unique to their own class of drugs. 
It has recently been demonstrated in rats that  the discrimi- 
native stimulus properties of  cyclazocine, a narcotic mixed 
agonist-antagonist ,  are similar to those of the dissociative 
anesthetics, ketamine and phencyclidine (Teal and Hol tzman 
1980). Independently, Shannon (1979) reported that SKF-  
10,047, the N-allyl-6,7-benzomorphan analogue of cycla- 
zocine, also produced discriminative effects similar to those of 
phencyclidine in the rat. In squirrel monkeys trained to 
discriminate cyclazocine from vehicle, dextrorphan and the 
closely related antitussive, dextromethorphan,  produce drug- 
appropria te  responding (Wiley and Hol tzman 1978). Thus, 
these pharmacological ly dissimilar compounds - i. e., dex- 
trorphan,  cyclazocine, and ketamine - appear  to share 
common discriminative stimulus effects. Indeed, Hol tzman 
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(1980) recently demonstrated that dextrorphan, cyclazocine, 
SKF-10,047, and ketamine resulted in drug-appropriate  
responding in rats trained to discriminate phencyclidine from 
saline. 
In order to examine the relationships among the in- 
teroceptive stimulus effects of  these drugs in another species, 
pigeons were trained to discriminate ketamine, cyclazocine, or 
dextrorphan from saline, and tests for generalization among 
these and other compounds were conducted. The spectrum of  
drug generalization among narcotics in the pigeon appears to 
be different from that  seen in other species (cf. Woods  et al. 
1980; Herling et al. 1980) and, thus, the pigeon provides an 
interesting species for comparative studies of  the discrimi- 
native stimulus properties of drugs. In addition, because the 
results of  tests of  stimulus generalization between drugs are 
not always symmetrical (e. g., Overton and Batta 1979), 
conclusions about  the degree of  stimulus similarity among 
compounds are strengthened when more than one drug is 
used as the training stimulus. 
Materials and Methods 
Subjects. A total of 12 White Carneaux pigeons, obtained from the 
Veterinary Animal Science Unit, Bowman-Gray Medical School, Win- 
ston-Salem, NC, were reduced to approximately 80 % of their free-feed- 
ing weights. Sufficient mixed grain and Purina Pigeon Checkers supple- 
mented the mixed grain earned during experimental sessions to maintain 
these reduced weights. All birds were experimentally-naive and drug- 
naive prior to the start of this study. 
Apparatus. Each experimental chamber had two translucent response 
keys (2 cm diameter and 5 cm apart) located 25 cm above the floor of the 
chamber and directly above the opening of the food receptacle. Through 
this opening, mixed grain could be made available from a hopper. A white 
light illuminated the hopper during food delivery. Each chamber was 
ventilated by an exhaust fan, and white noise was present to mask 
extraneous sounds. A more detailed description of the experimental 
chambers has been reported elsewhere (Herling et al. 1980). 
Programming, recording, and data collection were accomplished with a 
Texas Instruments 960A computer and cumulative recorders (model C: 
Ralph Gerbrands Co., Arlington MA). 
Procedure. Each pigeon was trained to peck at one of two key s by 
reinforcing successive approximations of the actual key-peck response 
with 4 s access to mixed grain. Following the acquisition of the response, 
the appropriate key to be pecked in order to produce grain access was 
determined by the injection the pigeon received prior to the session, e.g., 
drug (left key) or saline (right key). Across sessions, the number of 
consecutive responses required to produce grain was increased to 20. 
Inappropriate key responses reset the number requirement on the 




Training sessions were usually conducted six days per week. Drug 
discriminations were established with either cyclazocine (1.8mg/kg in 
three pigeons), dextrorphan (10 mg/kg in four pigeons, or 17.8 mg/kg in 
two pigeons) or ketamine (5 mg/kg in one pigeon, or 10mg/kg in two 
pigeons). In each bird, training was initiated and the discrimination 
sometimes established with the lower of the drug doses, but for individual 
pigeons, the drug dose was increased when the bird failed to meet the 
training criteria consistently. 
Training continued until each pigeon met the criteria of emitting 
fewer than 40 responses before the first grain presentation of the session 
and of distributing at least 90 % of the total session responses on the 
appropriate key. Each bird was required to meet these criteria for five 
consecutive sessions during which saline and drug injections alternated, 
and then on four consecutive sessions prior to which drug or saline was 
administered in a double alternation sequence (e.g., saline, saline, 
cyclazocine, cyclazocine). 
Once these criteria were met, test sessions were conducted with a 
range of doses of each of the training drugs, as well as with phencyclidine, 
nalorphine, and ethylketazocine. Throughout a test session, 20 con- 
secutive responses on either the drug-appropriate or saline-appropriate 
key produced access to grain; in all other respects, test sessions were 
identical to training sessions. In general, test sessions alternated during 
the week with training sessions. If during a training session an animal 
failed to meet the training criteria, further testing was postponed until the 
criteria were met on at least two consecutive training sessions. The order 
of drug administration and the dose sequence were irregular. A more 
detailed account of the procedure used in this experiment has previously 
been reported (Herling et al. 1980). 
Data Analysis. Data for test sessions are presented as the average number 
of responses throughout the session that were distributed on the drug- 
appropriate key, expressed as a percentage of the total emitted responses. 
In addition, the overall rate of key-peck responding after drug injection is 
presented as a percentage of the saline control rate. Saline control 
response rates were taken from saline training sessions within each drug 
series. 
Drugs. Dextrorphan tartrate (supplied by Dr. W. E. Scott, Hoffmann-La 
Roche, Nutley, N J), ketamine hydrochloride (provided by Dr. D. A. 
Downs, Warner-Lambert/Parke-Davis, Ann Arbor, MI), phencyclidine 
hydrochloride (supplied by Dr. R. Willette, NIDA, Rockville, MD), 
and nalorphine hydrochloride (provided by Dr. R. J. Hostey, Eli Lilly, 
Indianapolis, IN) were dissolved in 0.9 % sterile saline. Ethylketazocine 
methane sulfonate and cyclazocine base (provided by Dr. W. Michne, 
Sterling-Winthrop, Rensselaer, NY) were dissolved in sterile water 
to which a small amount of lactic acid was added; sodium hydroxide 
was then used to adjust the pH of these solutions to above 4. Drug 
doses refer to the forms described. Injections of all drugs and saline 
were made into the pectoral muscle, usually in a volume of 1 ml/kg, 
10 min prior to the start of the session. 
Results 
Each of  the pigeons  acqui red  the drug-saline discr iminat ion.  
The  number  of  sessions requi red  to meet  the t raining criteria 
ranged in individual  birds f rom 31 to 41 for the cyclazocine 
group,  36 to 44 for the ke tamine  group,  and 29 to 54 for the 
dex t ro rphan  group.  In  general, the differences in t raining 
doses used in this exper iment  resulted in few, if  any, 
differences ei ther in the main tenance  of  the drug-sal ine 
d iscr iminat ion  or  in the qual i ta t ive  na ture  of  the results o f  
subsequent  tests of  s t imulus general izat ion to o ther  drugs. 
Ke t amine  and phencycl idine p roduced  dose-dependent  
responding  on the d rug-appropr ia te  key in each group of  
pigeons,  with phencycl idine being approx imate ly  three to ten 
t imes more  po ten t  than ke tamine  (Fig. 1, upper  panels). Both  
drugs p roduced  d rug-appropr ia te  responding  in each group 
of  birds at doses that  resulted in an average decrease o f  less 







IOOF Kelomine-lroined Cyclozocineqmined Dextrorphon-troined 
g2 60 
T T I ~ t 
I0 0.1 I 10 0.1 I iO 
I l I I I I I I I I I I I 
I0 OJ I I0 0.I I0 
DOSE, mg/kg 
Fig. 1. Discriminative effects of phencyclidine and ketamine in birds 
trained to discriminate ketamine, cyclazocine, or dextrorphan from 
saline (upper panels); and the effects of these drugs on the rate of 
responding (lower panels). The upper panel ordinates indicate the 
average number of responses emitted on the drug-appropriate key, 
expressed as a percentage of the total session responses. The lower panel 
ordinates indicate the average rate of responding following drug 
injection, expressed as a percentage of the rate of responding on saline 
training sessions. The abscissae indicate the drug doses in mg/kg. Each 
point is the mean of a single observation in each of three birds, except 
that the effects of ketamine and phencyclidine were determined in only 
two cyclazocine-trained birds. *One ketamine-trained pigeon did not 
respond after 1.8 mg/kg phencyclidine 
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Fig. 2. Discriminative effects of cyclazocine, dextrorphan, ethylketa- 
zocine, and nalorphine in pigeons trained to discriminate ketamine, 
cyclazocine, or dextrorphan from saline (upper panels); and the effects of 
these drugs on the rate of responding (lower panels). Ordinates and 
abscissae, as in Fig. 1. Each point is the mean of a single observation in 
each of three birds~ except that effects of dextrorphan were determined in 
six dextrorphan-trained birds, the highest dose of dextrorphan 
(17.8 mg/kg) was administered to only five dextrorphan-trained birds, 
and the highest dose of nalorphine (100 mg/kg) was assessed in only two 
ketamine-trained birds. *One ketamine-trained bird did not respond 
following 3.2 mg/kg cyclazocine and a different ketamine-trained bird 
did not respond after 3.2 mg/kg ethylketazocine. No cyclazocine-trained 
bird responded 100 mg/kg nalorphine. One cyclazocine-trained bird 
(1002) died after the administration of this dose of nalorphine 
Cyclazocine and dex t ro rphan  also p roduced  dose-related,  
d rug-appropr ia te  responding  in each group of  pigeons 
(Fig. 2). Cyclazocine was three to five times more  po ten t  than  
dex t ro rphan  in p roduc ing  drug-appropr ia te  responses 
(Fig. 2, upper  panels) and in reducing response rates (Fig. 2, 
lower  panels). In each group of  birds, d rug-appropr ia te  
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Table 1. Discriminative effects of drugs in individual birds trained to discriminate ketamine from saline 
Test drug Dose Pigeon No. 
(mg/kg) 
947 1097 1155 
(5 mg/kg)" (10 mg/kg) (10 mg/kg) 
% Drug b Rate c % Drug Rate % Drug Rate 
Phencyclidine 0.1 0 126 0 123 0 91 
0.3 0 111 3 149 1 105 
1.0 I00 12 77 113 81 96 
1.8 ,d 0 91 7 94 5 
Ketamine 1.0 1 100 3 96 10 114 
3.2 85 92 13 75 83 129 
5.6 100 100 97 118 100 134 
10.0 100 66 99 90 92 86 
Cydazocine 0.3 1 107 2 99 0 103 
1.0 67 36 3 105 0 79 
1.8 95 10 44 80 13 78 
3.2 * 0 99 9 73 15 
Dextrorphan 1.0 3 133 0 88 0 100 
3.2 7 60 8 103 1 104 
5.6 69 31 14 94 0 102 
10.0 100 9 97 81 94 79 
Ethylketazocine 0.03 0 111 1 95 0 106 
0.1 0 83 1 95 6 92 
0.3 0 51 2 62 6 77 
1.0 2 37 11 42 0 6 
3.2 1 40 4 9 * 0 
Nalorphine 10.0 0 51 0 127 0 99 
32.0 0 12 1 34 0 78 
56.0 3 7 1 49 0 37 
100.0 0 17 0 10 
Given in parentheses under each pigeon's number is the training dose for that pigeon 
b Each entry is the percentage of total respones during the session that occurred on the drug-appropriate key 
c Each entry is the rate of key-peck responding after drug injection, expressed as a percentage of the saline control rate 
a Asterisks indicate that no responding occurred during the session 
responding occurred at doses of cyclazocine and dextrorphan 
that usually produced an average rate suppression of between 
20 and 40 % of the control rate of responding. In contrast to 
the effects of phencyclidine and each of the training drugs, 
ethylketazocine and nalorphine, at doses up to and including 
those that markedly suppressed response rates, resulted in 
responding that was generally restricted to the saline- 
appropriate key (Fig. 2). 
The performances of individual pigeons, some of which 
were trained with different training doses, are shown in 
Tables 1 - 3. Of the three ketamine-trained pigeons (Table 1), 
two were trained with 10 mg/kg (1097 and 1155) and one with 
5 mg/kg (947) of ketamine. The one bird trained with the 
lower of the ketamine doses (947) was somewhat more 
sensitive to the discriminative stimulus and rate-decreasing 
effects of phencyclidine, cyclazocine, and dextrorphan, but 
not ketamine, than the two birds trained at the higher 
ketamine dose (Table 1). 
In the dextrorphan-trained group (Table 2), birds were 
trained with either 10 or 17.8 mg/kg dextrorphan. One bird 
trained with the higher of the dextrorphan doses (898) was 
slightly lesssensitive to the discriminative effects of ketamine 
than birds trained at the lower dextrorphan dose. In this bird, 
more than 90 % drug-appropriate responding (91%) occurred 
only after 17.8 mg/kg of ketamine, a dose of the drug that 
reduced rate of responding to 22 % of the control rate. The 
difference in the training doses of dextrorphan, however, did 
not appear to affect differentially the response of these birds 
to cyclazocine or dextrorphan. 
Likewise, differences in the training doses of ketamine 
(Table 1) or dextrorphan (Table 2) did not affect the distri- 
bution of responses in these birds following injections of 
ethylketazocine or nalorphine. In contrast, the birds trained 
with a single dose of cyclazocine (1.8 mg/kg; Table 3) showed 
marked individual differences in their response to ethylketa- 
zocine, but  not to nalorphine. Ethylketazocine produced 
predominantly saline-appropriate responding in one 
cyclazocine-trained bird (708), responding intermediate be- 
tween that appropriate for cyclazocine or saline in a second 
bird (869), and a dose-dependent drug-appropriate response 
in a third (1002). 
Discussion 
The findings of the present experiment demonstrate that 
common components of the discriminable effects exist among 
phencyclidine, ketamine, cyclazocine, and dextrorphan. 
While it is unlikely that these drugs are identical in all their 
actions, some elements among a complex set of stimuli may be 
shared. For example, ethylketazocine produced varying 
Table 2. Discriminative effects of drugs in individual birds trained to discriminate dextrorphan from saline 
Test drug Dose Pigeon No. 
(mg/kg) 
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99 824 868 882 898 1153 
(10 mg/kg) a (10 mg/kg) (10 mg/kg) (10 mg/kg) (17.8 mg/kg) (17.8 mg/kg) 
Rate ~ ~ Rate ~ Rate ~o Rate ~ Rate ~ Rate 
Drugb Drug Drug Drug Drug Drug 
Phencylidine 0.1 0 85 0 104 
0.3 3 88 3 101 
1.0 97 83 100 62 
1.8 100 79 96 16 
Ketamine 0.3 0 104 0 107 
1.0 69 81 0 117 
3.2 100 102 56 87 
5.6 97 91 98 78 
10.0 98 72 96 53 
Cyclazocine 0.3 0 93 0 103 
1.0 95 96 0 105 
1.8 98 85 97 74 
3.2 100 5 95 7 
Dextrorphan 3.2 0 126 1 98 
5.6 25 111 25 100 
10.0 100 85 90 47 
17.8 92 9 96 37 
Ethylketazocine 0.1 1 84 0 137 
0.3 3 70 0 32 
1.0 0 64 0 49 
3.2 0 6 0 10 
Nalorphine 3.2 0 100 0 105 
10.0 1 71 1 114 
32.0 0 58 0 87 
56.0 0 54 3 12 







































































a, b, c Footnotes as in Table i 
amounts of  drug-appropr ia te  responding in the cyclazocine- 
trained pigeons, but  only sal ine-appropriate responding in 
the birds of  the other two groups, suggesting that  ethylketa- 
zocine and cyclazocine may share stimulus propert ies that are 
unlike those of  either ketamine or dextrorphan. 
These results in the pigeon corroborate  the findings of  a 
number of  other investigators who have recently noted 
similarities among the discriminative stimulus effects of  
phencyclidine, ketamine, cyclazocine, and dextrorphan in 
other species. In rats trained to discriminate phencyclidine 
from saline, for example, ketamine, cyclazocine, and dex- 
t rorphan produce phencyclidine-appropriate  responding 
(Shannon 1979; Hol tzman 1980). Similarly, rats trained to 
discriminate cyclazocine from saline generalize to ketamine 
and phencyclidine (Teal and Hol tzman 1980), and squirrel 
monkeys trained to discriminate between saline and cycla- 
zocine generalize to dextrorphan (Wiley and Hol tzman 1978). 
The relative potencies of  these drugs in producing discrimi- 
native effects in the pigeon are similar to those seen in rats. 
Phencyclidine is slightly more potent  than cyclazocine, and 
approximately ten to 15 times more potent  than dextrorphan 
(cf. Figs. 1 and 2; Hol tzman 1980). In agreement with the 
findings of  several others in rats, phencyclidine is three to ten 
times more potent  than ketamine in the pigeon (cf. Fig. 1; 
Overton 1975; Poling et al. 1979; Hol tzman 1980). 
The present findings in pigeons and those of others in rats 
(e. g., Shannon 1979; Teal and Hol tzman 1980; Hol tzman 
1980) also point  to differences between narcotics that share 
discriminative effects with ketamine or phencyclidine (e. g., 
cyclazocine) and narcotics such as ethylketazocine and nalor- 
phine. Ethylketazocine produces discriminative effects in the 
pigeon that  are similar to those of  morphine (Herling et al. 
1980). Conversely, neither ethylketazocine (Fig. 2) nor mor- 
phine (S. Herling, unpublished observations) produces re- 
sponding appropr ia te  for ketamine or dextrorphan. Holtz- 
man (1980) has proposed that in the rat  certain opioids, 
including cyclazocine and dextrorphan,  share with phencyc- 
lidine a common component  of  action that  is mediated by 
neuronal substrates not  usually associated with opiate ac- 
tivity. Phencyclidine-appropriate responding engendered by 
cyclazocine in rats, for example, is unaffected by 1.0 mg/kg 
naltrexone (Holtzman 1980). In pigeons, as well, the discrimi- 
native effects of  cyclazocine, dextrorphan,  and ketamine are 
not blocked by doses of  naltrexone as high as 10 mg/kg 
(S. Herling, unpublished observations). Thus, the nature of  
the phencyclidine, ketamine, cyclazocine, or dextrorphan 
discriminative stimulus appears to have little in common with 
that of  morphine-like narcotics. 
In the chronic spinal dog, one can also differentiate the 
profile of  phencyclidine's pharmacologic  effects (Vaupel and 
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Table 3. Discriminative effects of drugs in individual birds trained to discriminate cyclazocine from saline 
Test drug Dose Pigeon No. 
(mg/kg) 
708 869 i002 
(1.8mg/kg) a (l.Smg/kg) (1.8 mg/kg) 
Drug b Rate c ~ Drug Rate Drug Rate 
Phencydidine 0,1 0 113 0 101 
0.3 2 127 1 107 
1.0 100 64 100 86 
1.8 98 30 100 75 
Ketamine 1.0 1 111 10 89 
3.2 2 123 55 95 
5.6 1 116 94 106 
10.0 94 111 100 79 
Cydazocine 0.3 0 116 0 120 
1.0 1 109 98 97 
1.8 100 99 100 82 
3.2 93 7 98 5 
Dextrorphan 3.2 6 88 28 106 
10.0 97 67 100 108 
17.8 100 25 100 73 
Ethylketazocine 0.1 0 99 0 93 
0.3 6 86 0 105 
1.0 19 64 3 73 
3.2 5 37 48 84 
10.0 ,d 0 60 58 
Nalorphine 10.0 0 88 0 107 
32.0 3 87 10 65 
56.0 0 57 27 28 
















a, b, c, d Footnotes as in Table I 
Jasinski 1979; Jasinski et al. 1981) from that produced by 
morphine (e.g., Mart in et al. 1978), and from the effects 
produced by stimulants (Vaupel et al. 1978), barbiturates 
(Gilbert and Martin 1977), LSD, and THC (Vaupel and 
Jasinski 1979). In contrast, SKF-10,047 produces many acute 
effects in the chronic spinal dog that resemble those of 
phencyclidine, and cyclazocine shares a number of actions in 
this preparation with both compounds (cf. Martin et al. 1976; 
Gilbert and Martin 1976; Vaupel and Jasinski 1979; Jasinski 
et al. 1981). In man, the subjective effects of cyclazocine and 
SKF-I0,047 are distinguishable from those of morphine but 
have some aspects in common with phencyclidine and 
ketamine. These include sedation, disorientation, drunken- 
ness, and psychotomimetic symptomology (cf. Keats and Tel- 
ford 1964; Domino 1964; Domino et al. 1965 ; Haertzen 1974). 
Dextrorphan and its chemical congener, dextromethorphan, 
also produce subjective and physiologic effects in man that 
are distinguishable from those of morphine (Isbell and Fraser 
1953; Jasinski et al. 1971), and large doses of dextromethor- 
phan engender sedative-hypnotic effects and sensory distur- 
bances that closely resemble subjective effects produced by 
cyclazocine (Jasinski et al. 1971). 
Several investigators have suggested that the discrimi- 
native stimulus effects of drugs are analogous to the sub- 
jective effects of the drugs in man (e. g., Holtzman et al. 1977; 
Colpaert 1978). Teal and Holtzman (1980) have proposed 
that the similarity of the discriminative effects of cyclazocine, 
phencyclidine, and ketamine in the rat may be related to the 
psychotomimetic effects that these drugs produce in man. The 
results of the present study are consistent with this hypothesis. 
Cyclazocine, ketamine, phencyclidine, and dextrorphan pro- 
duced similar discriminative effects in the pigeon. Of these 
drugs, those that been evaluated in man appear to produce 
remarkably similar subjective effects. It may be, then, as in 
rats, that the discriminative stimulus effects of cyclazocine, 
ketamine, phencyclidine, and dextrorphan in pigeons are 
related to psychotomimetic and sedative-hypnotic effects that 
are produced by some of these drugs in man. 
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